Susceptibility Patterns of ESBL Positive Uropathogenic Escherichia coli to CLSI Recommended Group Drugs for Enterobacteriaceae

Autor/innen

  • Sekhar Mayani School of Environmental Sciences, Post Graduate and Research Department of Zoology, The New College, Chennai, India. – 600 014.
  • Dawood Sharief S School of Environmental Sciences, Post Graduate and Research Department of Zoology, The New College, Chennai,

Schlagwörter:

Uropathogenic E. coli, ESBL positive E. coli, antimicrobial resistance, CLSI recommended drugs

Abstract

Bacterial pathogens causing acute infections are increasingly exhibiting resistance to the commonly used antibiotics and have thus become a great threat to public health. The failure of empirical therapy is frequently observed, even in community-acquired urinary tract infections. We, therefore, conducted a study in 2009-10 to find out what proportion of urinary tract infections with Escherichia coli were caused by ESBL producers, the assessment susceptibility pattern of ESBL positive and negative isolates to antibiotics and correlate them with possible risk factors to assist empirical decision making. Antimicrobial susceptibility testing was performed for CLSI recommended drugs Enterobacteriaceae by Kirby-Bauer disk diffusion method. Of the 404 E. coli isolates, 174 (43%) were confirmed as ESBL producers whereas 230 (56.9%) E. coli isolates were non-ESBL producers. The rate of resistance for Ciprofloxacin was 96.6% in ESBL positive E. coli isolates and 62.7% in ESBL negative E. coli isolates. Respective values were: for Levofloxacin (98%) and (66%), for Ofloxacin and Norfloxacin (92%) and (56%), (66%), for Tetracycline (94%) and (65%), for Trimethoprim-sulfamethoxazole (76.3) and (52%), Tobramycin (72%) and(44%), for Gentamycin (60%) and 44% in community acquired urinary infection caused by E. coli isolates showing high prevalence of ESBL more than 43% isolates. ESBL positive E. coli isolates exhibited high resistance to CLSI recommended antimicrobial agents when compared to non-ESBL E. coli isolates. ESBL producers are serious threat to public health necessitating continuous surveillance and use of appropriate screening tests for laboratory detection to control the further spread of resistance.

Downloads

Veröffentlicht

2013-02-19

Ausgabe

Bd. 2 Nr. 3 (2012)

Rubrik

Research Articles

Lizenz

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.